Finanzwire Finanzwire
Basculer en Français
11027 Companies
241680 Keywords
170146 Articles
130117 Press releases
Headlines Articles Press releases TRANSGENE Remove
  1. Home
  2. Companies
  3. TRANSGENE
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 06/03/2024 at 07:35, 2 years 3 months ago

    Transgene includes the first patient in Phase II of the study of its TG4050 vaccine against head and neck cancers

    Head And Neck Cancer Transgene TG4050 Phase II Therapeutic Vaccine
  • PRESS RELEASE

    published on 06/03/2024 at 07:30, 2 years 3 months ago

    Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine TG4050 in Head and Neck Cancer

    Transgene enrolls first patient in Phase II of randomized Phase I/II trial for cancer vaccine TG4050 in head and neck cancer, with completion expected in Q4 2025
    Phase II Trial Head And Neck Cancer Cancer Vaccine Transgene TG4050
    Logo of TRANSGENE
  • BRIEF

    published on 05/14/2024 at 17:50, 2 years 4 months ago

    Transgene Announces Positive Q1 2024 Update and Future Clinical Milestones

    Clinical Trials Financial Update Cancer Immunotherapy Transgene TG4050
  • PRESS RELEASE

    published on 05/14/2024 at 17:45, 2 years 4 months ago

    Transgene provides business and financial update for Q1 2024

    Transgene provides business and financial update for Q1 2024, including promising Phase I data on TG4050 and upcoming clinical data expectations on TG4001, TG6050, and BT-001 in H2 2024
    Clinical Data Q1 2024 Financial Update Transgene TG4050
    Logo of TRANSGENE
Previous page
1 ... 6 7
Accesswire
  • Published on 09/19/2026 at 00:55, 1 day 5 hours ago

    Gossan Resources Announces Changes to Board and Management

  • Published on 09/18/2026 at 23:50, 1 day 6 hours ago

    Mako Mining Announces Equity Incentive Grants

  • Published on 09/18/2026 at 22:00, 1 day 8 hours ago

    Silver Tiger Announces Results of Annual and Special Meeting

  • Published on 09/18/2026 at 20:35, 1 day 9 hours ago

    Only 11% of Marketers Expect Google Search to Be Their Customers' Main Starting Point in Two Years

  • Published on 09/18/2026 at 14:30, 1 day 15 hours ago

    AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement

View all ACCESSWIRE
EQS Group
  • Published on 09/20/2026 at 04:35, 1 hour 28 minutes ago

    How to Achieve Sustainable Power Without Changing Your Existing Backup System

  • Published on 09/19/2026 at 16:40, 13 hours 23 minutes ago

    2026 Cross-Strait (Kunshan) Mid-Autumn Lantern Festival Opens

  • Published on 09/19/2026 at 13:15, 16 hours 49 minutes ago

    Eurobattery Minerals AB has received information regarding court judgment and criminal suspicion concerning the CEO

  • Published on 09/19/2026 at 07:30, 22 hours 34 minutes ago

    Hong Kong sets out initiatives to secure long-term development of pillar industries

  • Published on 09/18/2026 at 18:45, 1 day 11 hours ago

    Holding(s) in Company

View all EQS
Les Echos
  • Published on 09/18/2026 at 18:34, 1 day 11 hours ago

    Disclosure of transactions in own shares from September 14 to September 18, 2026

  • Published on 09/18/2026 at 17:45, 1 day 12 hours ago

    Press Release_Carrefour Bond_September 2026

  • Published on 09/18/2026 at 17:45, 1 day 12 hours ago

    Share buyback for cancellation

  • Published on 09/17/2026 at 17:40, 2 days 12 hours ago

    Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany

  • Published on 09/16/2026 at 20:46, 3 days 9 hours ago

    LNA SANTE : 2026 First Half Results

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy